alexa Abstract | How Safe Are Short Acting Calcium Channel Blockers In Hypertension?

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


The controversies surrounding the use of short acting calcium channel blockers in hypertension are discussed. Much of the controversy has been generated by the study conducted by Psaty et al. The study concluded that the use of calcium channel blockers was associated with a 58% to 70% increased risk of suffering from myocardial infarction than with diuretics. In another trial named Appropriate Blood Pressure Control in Diabetes (ABCD), which compared nisoldipine and enalapril, was stopped early because of an excess of myocardial infarction (MI) amongst the patients taking calcium channel blockers (CCB). However amlodipine, a long acting CCB has shown to be beneficial in hypertension and has been widely prescribed. Based on the implications and limitations of the data available for the treatment of hypertension, suggestions were given for the selection of a suitable regimen.

To read the full article Peer-reviewed Article PDF image

Author(s): S D Rajendran S Ponnusankar S Lakhvinder S Batolar

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us